Latest filing published 04 Oct 2023 for RenovoRx, Inc., €802.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -11.3%Entry US$1.15 · Close at T+365 US$1.02
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Angela Nelms: trading record in brief
All filings by Angela Nelms on record concern RenovoRx, Inc. The record holds 2 filings, all for trades on 3 October 2023.
Purchases make up the whole of the open-market record (2 purchases, €1,103). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 4 October 2023, reports an open-market purchase of €802 in RenovoRx, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Angela Nelms
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 800 shares@ US$1.0572.7% of flowCommon StockSEC:0001493152-23-035684:1Canonical exit: 1 Jan 2024 (T+90)
- 300 shares@ US$1.0499100.0% of flowCommon StockSEC:0001493152-23-035684:0Canonical exit: 1 Jan 2024 (T+90)
2 of 2 declarations